Professor Jens K. Habermann, M.D., PH.D., is Director General of BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure – European Research Infrastructure Consortium) since September 2020. 

He is on leave of absence from the University of Lübeck as Head of the Section of Translational Surgical Oncology and Biobanking and as Head of ICB-L (Interdisciplinary Center for Biobanking-Lübeck).

Jens obtained his M.D. training at the Medical University of Lübeck, Germany, received his Ph.D. at the Cancer Center Karolinska, Karolinska Institute, Sweden and a Postdoctoral Fellowship at the National Cancer Institute, NIH, USA. 

As board certified specialist in human genetics, Prof. Habermann combines clinics, biobanking, and translational (cancer) research to optimize precision medicine.

On October 8 at Rigshospitalet, Jens will chair at the roundtable discussion 4: Advancing personalized medicine and prevention through the power of data and AI for breakthrough innovation.